Skip to main content
. 2021 Oct 26;22(21):11552. doi: 10.3390/ijms222111552

Table 4.

Emerging Investigational Radiotracers of Infection Imaging.

Radiotracer Clinical Trials Parameter Mechanism of Localization Strength/Weakness References
Radiolabeled Antibiotics 99mTc-ciprofloxacin Yes Inhibition of DNA Synthesis Bacterial DNA gyrase High sensitivity (85.4–97.2%), ciprofloxacin already used in DFI treatment [133,134,135,136]
Low specificity (66.7–81.7%), antibiotic resistant bacteria
18F-fluoropropyl-trimethoprim No Inhibition of Folic Acid Synthesis Inhibition of thymidine biosynthesis Low background, high uptake in bacteria, detect inflammation from soft tissue infection vs sterile inflammation [167]
Antibiotic resistant bacteria
99mTc-sulfonamides (pertechnetate, sulfadiazine) No Inhibition of Folic Acid Synthesis Broad spectrum antibiotics, uptake in bacterial and fungal infections [155]
Antibiotic resistant bacteria
99mTc-vancomycin No Inhibition of bacterial cell wall synthesis Binds to D-ala-D-ala lipid moiety Specific for gram positive organisms [137,138,139]
Not specific for gram negative organisms
Antibiotic resistant bacteria
Radiolabeled Sugars 18F-FDS Yes Bacteria-Specific Glucose Sources for Carbohydrate Metabolism Bacterial Metabolic Substrate Antibiotic treatment monitoring, used in humans [140,141]
Uptake by Enterobacteriaceae in the human gut
18F-FAG No Sorbitol analogue utilized only by bacteria Selective accumulation in E. coli, rapid accumulation, can differentiate infection from sterile inflammation, shows promise for monitoring response to treatment, small molecule [142]
Not applied clinically
18F-maltohexose No Bacterial-specific maltodextrin transporter Can discriminate between live bacteria, metabolically inactive bacteria, and sterile inflammation [143]
Poor signal-to-noise ratios, Not applied clinically
6′′-18F-fluoromaltotriose No Bacterial-specific maltodextrin transporter 2nd Gen, improved signal-to-noise ratio, bacterial-selective uptake in vitro and in vivo [144,145]
Not applied clinically
Amino Acid Uptake D-[methyl-11C] methionine No Bacterial Cell Wall Synthesis Incorporation into the peptidoglycan Distinguish sterile inflammation from infection in both gram—and gram +, broad sensitivity [146,147]
Not applied clinically
D-5-[11C] glutamine No Incorporation into the peptidoglycan Highly specific, high sensitivity for gram +, no uptake in sterile inflammation, fast clearance [148]
Corroborating studies needed, not yet applied clinically
Vitamin Uptake 124I-fialuridine (FIAU) Yes Endogenous TK enzyme of pathogenic bacteria Trapped in the cell after phosphorylation Reduced uptake in the presence of metal artifacts, [154,168,169]
More clinical studies needed to assess clinical efficacy
111In-biotin No Production of Fatty Acid Bacterial growth factor Essential growth factor for S. aureus [149]
Corroborating in vivo studies needed to assess clinical relevance
99mTc-PAMA No Vitamin B12 Metabolism Vitamin B12 derivative that accumulates in rapidly proliferating cells High uptake in Gram + and Gram - [150]
Not applied clinically
18F or 3H-PABA No Folic Acid Synthesis Inhibition of Thymidine Synthesis Accumulation in MRSA and other resistant organisms [151]
In vivo studies needed
Polyclonal Antibodies 64Cu-NODAGA No Membrane protein binding of polyclonal antibody Microbe-specific membrane polyclonal antibody binding Particular to a specific microbe [164,165]
Slow accumulation time
Siderophores 68Ga-FOXE No Iron Transport Accumulation of Siderophores in the cell High uptake in S. aureus and fungi [160,161,162]
Not used in DFI model
Immunoscintigraphy 99mTc-sulesomab Yes WBC migration to infectious foci Binds to antigen-90 on WBC membranes Ease of preparation? Not sure about this [63,71]
Dependent upon host response, expensive, limited availability
99mTc-Besilesomab Binds to antigen-95 on granulocytes and their precursors Ease of preparation, good sensitivity and specificity [63]
Dependent upon host response, expensive, limited availability

Table adapted from Ankrah et al. (2018) [131].